Pharmaids Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lacs)
Pharmaids Pharmaceuticals Ltd · Outcome · 12 Nov 2026, 12:53 am
Pharmaids Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lacs) ■ Revenue: 434 (-49.6% YoY | +5.2% QoQ) ■ EBITDA: -128 (+78.7% YoY | -72.4% QoQ) ■ EBITDA Margin (%): -29.6 (+4039 bps YoY | -1154 bps QoQ) ■ PAT: -210 (+34.0% YoY | Profit to Loss QoQ) ■ EPS (INR): -0.60 (+33.3% YoY | Profit to Loss QoQ)
Original exchange filing (PDF)
More announcements from Pharmaids Pharmaceuticals Ltd
- Submission of unaudited financial results for quarter and half year ended 30th September 2026 · 12 Nov 2026
- Pharmaids Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2026 ,inter alia, to consider and approve the Unaudited Financial .... · 11 Nov 2026
- Pursuant to the Regulation 30(3) & 30(4) read with Para B of Part A of Schedule III of SEBI (Listing Obligations and Disclosure requirements) Regulations 2015, we hereby inform that the .... · 16 Sept 2026
- Voting Results along with the Scrutinizer''s Report of the 37th AGM of the Company held on 11th September 2026 through VC/ OAVM. · 15 Sept 2026
- Outcome of the 37th Annual General Meeting of the Company held on September 11, 2026 i.e., today at 12 noon through VC/OAVM. · 11 Sept 2026
- Annual Report · 18 Aug 2026
- Notice of 37th AGM and Annual Report · 18 Aug 2026
- Submission of unaudited financial results · 13 Aug 2026
